Gerald J. Goldenberg
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer therapeutics and mechanisms 12
- Retinoids in leukemia and cellular processes 9
- DNA Repair Mechanisms 5
- Oncology 17
- Co-authors
- Asher Begleiter (15 shared papers)Abdul M. Deffie (6 shared papers)Janendra K. Batra (3 shared papers)D. A. G. Galton (1 shared paper)Daniel Catovsky (1 shared paper)J M Goldman (1 shared paper)E. Wiltshaw (1 shared paper)K. Henry (1 shared paper)
- Journals
- Biochemical Pharmacology (10 papers)Nature (4 papers)Leukemia Research (3 papers)Cancer (3 papers)Cancer Letters (1 paper)
- Partner nations
- CanadaUnited StatesIsrael
In The Last Decade
Gerald J. Goldenberg
77 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 102
- Genetics 329
- Toxicology 111
- Oncology 828
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 283
Countries citing papers authored by Gerald J. Goldenberg
This map shows the geographic impact of Gerald J. Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald J. Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald J. Goldenberg more than expected).
Fields of papers citing papers by Gerald J. Goldenberg
This network shows the impact of papers produced by Gerald J. Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald J. Goldenberg. The network helps show where Gerald J. Goldenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald J. Goldenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 298 | |
| 2 | Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. | 1989 | 222 |
| 3 | Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. | 1988 | 175 |
| 4 | 1979 | 108 | |
| 5 | Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178Y lymphoblasts. | 1970 | 78 |
| 6 | 1969 | 69 | |
| 7 | Evidence for active transport of melphalan by two amino acid carriers in L5178Y lymphoblasts in vitro. | 1979 | 67 |
| 8 | 1971 | 66 | |
| 9 | Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. | 1986 | 66 |
| 10 | Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. | 1987 | 54 |
| 11 | Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. | 1995 | 51 |
| 12 | 1983 | 49 | |
| 13 | 1985 | 48 | |
| 14 | 1980 | 42 | |
| 15 | Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells. | 1989 | 42 |
| 16 | Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha. | 1998 | 40 |
| 17 | Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro. | 1982 | 39 |
| 18 | 1979 | 37 | |
| 19 | 1974 | 35 | |
| 20 | 1990 | 34 |
About Gerald J. Goldenberg
Gerald J. Goldenberg is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Public Health, Environmental and Occupational Health and Cancer Research, having authored 78 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Synthesis and Biological Evaluation (12 papers), Retinoids in leukemia and cellular processes (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Carcinogens and Genotoxicity Assessment (8 papers), Bioactive Compounds and Antitumor Agents (6 papers), Estrogen and related hormone effects (6 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Genetics (329 citations), Toxicology (111 citations), Oncology (828 citations), Molecular Biology (1.3k citations) and Pathology and Forensic Medicine (283 citations). Gerald J. Goldenberg has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include Asher Begleiter, Abdul M. Deffie, Janendra K. Batra, D. A. G. Galton, Daniel Catovsky, J M Goldman, E. Wiltshaw, K. Henry, Hing-Yat Peter Lam and I. Bihler. Their work appears in journals such as Biochemical Pharmacology, Nature, Leukemia Research, Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.